Investigating Near-Threshold Perception During Anesthetic Sedation

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

May 10, 2024

Primary Completion Date

October 3, 2025

Study Completion Date

October 3, 2025

Conditions
PropofolAnesthesiafMRI
Interventions
COMBINATION_PRODUCT

Functional Magnetic Resonance Imaging (fMRI) with propofol

Three 16-min sessions in wakeful baseline, light sedation, and recovery will be conducted (Fig. 2). Light sedation will be achieved by IV infusion of propofol to achieve effect-site concentrations of 1.0 μg/ml. Infusion rate will be manually controlled. An initial bolus dose (525 µg/kg) and subsequent infusion rate (82 µg/kg/min) for each participant

Trial Locations (1)

48109

University of Michigan, Ann Arbor

All Listed Sponsors
collaborator

National Institute of General Medical Sciences (NIGMS)

NIH

lead

University of Michigan

OTHER

NCT06403852 - Investigating Near-Threshold Perception During Anesthetic Sedation | Biotech Hunter | Biotech Hunter